Skip to main content
Clinical Trials/NCT03682198
NCT03682198
Completed
N/A

Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions

University Hospital Bispebjerg and Frederiksberg1 site in 1 country18 target enrollmentSeptember 24, 2018

Overview

Phase
N/A
Intervention
NIRS measurements on skin, skull and dura
Conditions
Neurosurgery
Sponsor
University Hospital Bispebjerg and Frederiksberg
Enrollment
18
Locations
1
Primary Endpoint
ScO2 (NIRS-measured cerebral oxygen saturation)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This is a prospective observational study, consisting of 3 substudies carried out during elective neurosurgery under general anaesthesia. Each participant will take part in all 3 substudies. First, the capability of Near Infra Red Spectroscopy (NIRS) to measure the brain oxygenation is examined. A NIRS-electrode is placed on forehead skin, on the skull, and on dura. Secondly, a small dose of Phenylephrine is given, and the brain oxygenation is measured by a Clark-electrode and a NIRS-electrode, to see how Phenylephrine affects these measurements. In the third substudy, the brain oxygenations' (NIRS and Licox) response to an inspired oxygen fraction of 0.30 vs. 0.80 is investigated.

Registry
clinicaltrials.gov
Start Date
September 24, 2018
End Date
October 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital Bispebjerg and Frederiksberg
Responsible Party
Principal Investigator
Principal Investigator

Sofie Pedersen

MD, Primary Investigator

University Hospital Bispebjerg and Frederiksberg

Eligibility Criteria

Inclusion Criteria

  • Adult (\>18 years) patients
  • Elective craniotomy

Exclusion Criteria

  • Repeat craniotomy
  • Preoperative hypotension (defined as systolic blood pressure below 110 mmHg)
  • Preoperative hypoxia (defined as peripheral oxygen saturation (SpO2) \< 90% without oxygen supplementation before surgery)
  • No negative pregnancy test for women \<50 years.

Arms & Interventions

One strategy for all enrolled patients:

All patients will participate in three substudies, in which they also act as controls, with exposure to the same three interventions: 1) NIRS-measurement on skin, skull and dura, 2) Phenylephrine 0.1 mg iv., and 3) inspired oxygen fraction of 0.3 vs. 0.8

Intervention: NIRS measurements on skin, skull and dura

One strategy for all enrolled patients:

All patients will participate in three substudies, in which they also act as controls, with exposure to the same three interventions: 1) NIRS-measurement on skin, skull and dura, 2) Phenylephrine 0.1 mg iv., and 3) inspired oxygen fraction of 0.3 vs. 0.8

Intervention: Phenylephrine's effect on brain oxygenation

One strategy for all enrolled patients:

All patients will participate in three substudies, in which they also act as controls, with exposure to the same three interventions: 1) NIRS-measurement on skin, skull and dura, 2) Phenylephrine 0.1 mg iv., and 3) inspired oxygen fraction of 0.3 vs. 0.8

Intervention: Normal vs. high inspired oxygen

Outcomes

Primary Outcomes

ScO2 (NIRS-measured cerebral oxygen saturation)

Time Frame: During surgical procedure

Difference in ScO2 between dura and skin (Primary analysis for substudy 1)

Secondary Outcomes

  • PBrO2 (Partial pressure of brain tissue oxygen)('Normoxia' is induced with FiO2 = 0.30 for 5 minutes, and then changed to 'Hyperoxia' with FiO2 = 0.80 for the subsequent 5 minutes, while registering the Licox-signal.)
  • ScO2 (NIRS-measured cerebral oxygen saturation)(Measurements will be performed as the surgeon exposes the skull.)
  • ScO2 (NIRS-measured cerebral oxygenation)(NIRS signal is obtained continuously during the Phenylephrine intervention)

Study Sites (1)

Loading locations...

Similar Trials